Company Filing History:
3 out of 1,745 
3 out of 85 
3 out of 132 
Years Active: 2015-2019
Title: Patrick Rossignol: Innovator in Cardiovascular Treatment
Introduction
Patrick Rossignol is a notable inventor based in Vandoeuvre-les-Nancy, France. He has made significant contributions to the field of cardiovascular medicine, particularly through his innovative patents. With a total of three patents to his name, Rossignol's work focuses on methods for treating cardiovascular fibrosis.
Latest Patents
Among his latest patents, Rossignol has developed methods and pharmaceutical compositions aimed at treating cardiovascular fibrosis. His inventions specifically relate to the use of an inhibitor of Neutrophil Gelatinase-Associated Lipocalin (NGAL) activity or expression. These methods are designed for treating or preventing cardiovascular fibrosis in individuals who require such interventions.
Career Highlights
Throughout his career, Patrick Rossignol has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Lorraine. His research and innovations have positioned him as a key figure in the medical community, particularly in the realm of cardiovascular health.
Collaborations
Rossignol has collaborated with prominent professionals in his field, including Frederic Jaisser and Faiez Zannad. These partnerships have further enhanced his research and contributed to the advancement of treatment methods for cardiovascular conditions.
Conclusion
In summary, Patrick Rossignol is a distinguished inventor whose work in cardiovascular treatment has led to significant advancements in medical science. His innovative patents and collaborations reflect his commitment to improving health outcomes for patients suffering from cardiovascular fibrosis.